Interpace Biosciences Announces New Real-world Data;

PARSIPPANY, NJ, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial...

Related Keywords

United States ,American ,Syd Finkelstein ,Interpace Biosciences ,Interpace Bioscience ,Tom Burnell ,Exchange Commission ,Company Annual Report On Form ,Interpace Diagnostics ,Interpace Biosciences Inc ,Securities Exchange ,Comerica Bank ,American Thyroid Association ,Benign Call Rate ,Chief Scientific Officer ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Annual Report ,Current Reports ,Quarterly Reports ,Other Otc Idxg ,Nc ,Tcqx Idxg ,Hygenext 174 ,Hyramir 174 V2 ,Tn ,Data ,New Real World Data ,2022 Annual Meeting ,Dirna ,Hygenext ,